236
Views
7
CrossRef citations to date
0
Altmetric
Research Article

In vitro and in vivo evaluation of 99mTc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors

, , &
Pages 761-769 | Received 11 Oct 2010, Accepted 01 Feb 2011, Published online: 22 Mar 2011
 

Abstract

Background: The cell membrane folate receptor is a potential molecular target for tumor selective drug delivery via receptor-mediated endocytosis, including delivery of radiolabeled folate-chelate conjugates for diagnostic imaging.

Method: A new radiopharmaceutical, 99mTc-1,4,7-tris (carboxymethyl)-10-(4-aminoethyl)-1,4,7,10-tetraazacyclododecane (DO3A-EA)-Folate has been synthesized introducing DO3A-EA to the γ-carboxyl group of folic acid and was characterized by different spectroscopic techniques. Cytotoxicity was determined by macrocolony and MTT assay on three different cell lines. Cell uptake studies and receptor binding assay were performed using 99mTc-DO3A-EA-Folate. Tumor imaging was performed in KB cell line implanted tumor bearing nude mice, and uptake of the radiotracer was estimated.

Results: The synthesized conjugate binds with 99mTc at high efficiency at ambient temperature. The resulting conjugate is stable under physiological conditions for 24 h after radiocomplexation. Using an in vitro receptor binding assay, the conjugate showed Kd in μM range on human tumor cell lines (KB, U-87MG and OAW). The pharmacokinetic data revealed rapid wash out of the more than 75% activity within 5 min from the circulation with hepato-biliary clearance. Data from γ scintigraphic and biodistribution studies performed in KB tumor bearing nude mice revealed major accumulation of radiotracer at tumor site. High tumor uptake was shown in the tumor bearing mice; tumor to blood ratios reached 2.27 ± 0.32 and 6.05 ± 1.02 at 1 and 4 h after post injection, respectively.

Conclusion: These results suggest that 99mTc-DO3A-EA-Folate may be clinically useful as a noninvasive radiodiagnostic imaging agent for the detection of FR-positive human cancers.

Acknowledgments

We are grateful to Dr. R. P. Tripathi, Institute of Nuclear Medicine and Allied Sciences, University of Delhi, for providing support and commendable research facilities.

Declaration of interest

The work was supported by Defence Research and Development Organization, Ministry of Defence, under R&D Project INM-311.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 767.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.